GSA Capital Partners LLP acquired a new position in Maximus, Inc. (NYSE:MMS) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 19,124 shares of the health services provider’s stock, valued at approximately $1,198,000.

A number of other institutional investors and hedge funds also recently modified their holdings of MMS. BlackRock Inc. lifted its holdings in Maximus by 22,491.0% in the first quarter. BlackRock Inc. now owns 6,503,511 shares of the health services provider’s stock worth $404,518,000 after buying an additional 6,474,723 shares during the period. Clearbridge Investments LLC lifted its holdings in Maximus by 49.5% in the first quarter. Clearbridge Investments LLC now owns 2,004,270 shares of the health services provider’s stock worth $124,666,000 after buying an additional 663,189 shares during the period. Columbia Wanger Asset Management LLC lifted its holdings in Maximus by 115.7% in the first quarter. Columbia Wanger Asset Management LLC now owns 787,691 shares of the health services provider’s stock worth $48,994,000 after buying an additional 422,499 shares during the period. Vanguard Group Inc. lifted its holdings in Maximus by 8.0% in the first quarter. Vanguard Group Inc. now owns 5,538,187 shares of the health services provider’s stock worth $344,476,000 after buying an additional 411,521 shares during the period. Finally, Trilogy Global Advisors LP purchased a new stake in Maximus in the second quarter worth about $17,325,000. Institutional investors and hedge funds own 97.23% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “GSA Capital Partners LLP Acquires New Holdings in Maximus, Inc. (MMS)” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another website, it was illegally copied and republished in violation of international copyright & trademark laws. The original version of this piece can be accessed at https://www.thecerbatgem.com/2017/09/28/gsa-capital-partners-llp-acquires-new-holdings-in-maximus-inc-mms.html.

MMS has been the subject of several research analyst reports. Robert W. Baird initiated coverage on shares of Maximus in a report on Sunday, September 3rd. They issued a “neutral” rating for the company. Zacks Investment Research lowered shares of Maximus from a “hold” rating to a “sell” rating in a report on Tuesday, July 18th. BidaskClub lowered shares of Maximus from a “strong-buy” rating to a “buy” rating in a report on Thursday, July 6th. Maxim Group set a $66.00 target price on shares of Maximus and gave the company a “hold” rating in a report on Thursday, August 3rd. Finally, Canaccord Genuity lowered shares of Maximus from a “buy” rating to a “hold” rating and set a $62.00 target price for the company. in a report on Tuesday, July 4th. One analyst has rated the stock with a sell rating and nine have given a hold rating to the stock. Maximus presently has an average rating of “Hold” and an average price target of $62.43.

Shares of Maximus, Inc. (NYSE MMS) opened at 65.06 on Thursday. Maximus, Inc. has a 52-week low of $43.69 and a 52-week high of $65.37. The firm has a 50-day moving average of $60.88 and a 200-day moving average of $61.50. The company has a market cap of $4.22 billion, a P/E ratio of 20.85 and a beta of 1.37.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, August 3rd. The health services provider reported $0.79 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.76 by $0.03. The business had revenue of $600.40 million during the quarter, compared to analysts’ expectations of $614.12 million. Maximus had a net margin of 8.43% and a return on equity of 25.08%. The business’s quarterly revenue was down 2.7% on a year-over-year basis. During the same quarter last year, the company posted $0.79 earnings per share. Equities research analysts forecast that Maximus, Inc. will post $3.13 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Thursday, August 31st. Shareholders of record on Tuesday, August 15th were issued a $0.045 dividend. The ex-dividend date of this dividend was Friday, August 11th. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.28%. Maximus’s dividend payout ratio is currently 5.73%.

In other news, CEO Richard A. Montoni sold 29,203 shares of the stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $60.38, for a total value of $1,763,277.14. Following the sale, the chief executive officer now owns 549,215 shares in the company, valued at $33,161,601.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, President Bruce Caswell sold 8,000 shares of the stock in a transaction on Monday, September 18th. The stock was sold at an average price of $63.28, for a total transaction of $506,240.00. Following the completion of the sale, the president now owns 35,904 shares in the company, valued at approximately $2,272,005.12. The disclosure for this sale can be found here. In the last ninety days, insiders sold 132,403 shares of company stock valued at $8,088,341. Corporate insiders own 3.10% of the company’s stock.

Maximus Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Stock Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related stocks with our FREE daily email newsletter.